Cannabis
109
18
27
57
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
17 trials with published results (16%)
Research Maturity
57 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.9%
1 terminated out of 109 trials
98.3%
+11.8% vs benchmark
4%
4 trials in Phase 3/4
30%
17 of 57 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 57 completed trials
Clinical Trials (109)
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Repeated CBD Administration and Cannabis Outcomes
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
Cannabinoids, Learning, and Memory
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
Reducing Breathlessness With Dronabinol in COPD Patients
Repeated Administration of Cannabis Varying in THC and CBD
Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
Age Differences in the Effects of Cannabis on Simulated Driving
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study
Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use
Sex Hormones Impact on Cannabis Response
A Virtual Reality Game to Prevent E-cigarette and Cannabis Vaping
Changes in Cognition and Psychiatric Disorder Symptoms During Cannabis Abstinence Using a Novel Discordant Twin Design